ChemMedChem, volume 10, issue 10, pages 1629-1634

Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses

Braun Heike 2
Richter Martina 2
Riabova Olga B 1
Kirchmair Johannes 3
Kazakova Elena S 1
Seidel Nora 2
Wutzler P. 2
Schmidtke Michaela 2
2
 
Virology & Antiviral Therapy, Jena University Hospital, Hans-Knöll-Str. 2, 07745 Jena (Germany)
3
 
Center for Bioinformatics, University of Hamburg, Bundesstrasse 43, 20146 Hamburg (Germany)
Publication typeJournal Article
Publication date2015-08-10
Journal: ChemMedChem
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor3.4
ISSN18607179, 18607187
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
General Pharmacology, Toxicology and Pharmaceutics
Abstract
There are currently no drugs available for the treatment of enterovirus (EV)-induced acute and chronic diseases such as the common cold, meningitis, encephalitis, pneumonia, and myocarditis with or without consecutive dilated cardiomyopathy. Here, we report the discovery and characterization of pyrazolopyrimidines, a well-tolerated and potent class of novel EV inhibitors. The compounds inhibit the replication of a broad spectrum of EV in vitro with IC50 values between 0.04 and 0.64 μM for viruses resistant to pleconaril, a known capsid-binding inhibitor, without affecting cytochrome P450 enzyme activity. Using virological and genetics methods, the viral capsid was identified as the target of the most promising, orally bioavailable compound 3-(4-trifluoromethylphenyl)amino-6-phenylpyrazolo[3,4-d]pyrimidine-4-amine (OBR-5-340). Its prophylactic as well as therapeutic application was proved for coxsackievirus B3-induced chronic myocarditis in mice. The favorable pharmacokinetic, toxicological, and pharmacodynamics profile in mice renders OBR-5-340 a highly promising drug candidate, and the regulatory nonclinical program is ongoing.

Citations by journals

1
2
3
4
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 4, 12.12%
European Journal of Medicinal Chemistry
4 publications, 12.12%
Planta Medica
Planta Medica, 3, 9.09%
Planta Medica
3 publications, 9.09%
ChemistrySelect
ChemistrySelect, 2, 6.06%
ChemistrySelect
2 publications, 6.06%
Viruses
Viruses, 1, 3.03%
Viruses
1 publication, 3.03%
Cells
Cells, 1, 3.03%
Cells
1 publication, 3.03%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 3.03%
Frontiers in Microbiology
1 publication, 3.03%
Frontiers in Chemistry
Frontiers in Chemistry, 1, 3.03%
Frontiers in Chemistry
1 publication, 3.03%
Journal of Plant Growth Regulation
Journal of Plant Growth Regulation, 1, 3.03%
Journal of Plant Growth Regulation
1 publication, 3.03%
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies, 1, 3.03%
BMC Complementary Medicine and Therapies
1 publication, 3.03%
Pharmaceutics
Pharmaceutics, 1, 3.03%
Pharmaceutics
1 publication, 3.03%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 1, 3.03%
Bioorganic and Medicinal Chemistry
1 publication, 3.03%
Virus Research
Virus Research, 1, 3.03%
Virus Research
1 publication, 3.03%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 3.03%
Journal of Medicinal Chemistry
1 publication, 3.03%
Pharmaceuticals
Pharmaceuticals, 1, 3.03%
Pharmaceuticals
1 publication, 3.03%
New Journal of Chemistry
New Journal of Chemistry, 1, 3.03%
New Journal of Chemistry
1 publication, 3.03%
Russian Journal of Organic Chemistry
Russian Journal of Organic Chemistry, 1, 3.03%
Russian Journal of Organic Chemistry
1 publication, 3.03%
Expert Opinion on Therapeutic Targets
Expert Opinion on Therapeutic Targets, 1, 3.03%
Expert Opinion on Therapeutic Targets
1 publication, 3.03%
Journal of Experimental Pharmacology
Journal of Experimental Pharmacology, 1, 3.03%
Journal of Experimental Pharmacology
1 publication, 3.03%
Clinical Infectious Diseases
Clinical Infectious Diseases, 1, 3.03%
Clinical Infectious Diseases
1 publication, 3.03%
Green Processing and Synthesis
Green Processing and Synthesis, 1, 3.03%
Green Processing and Synthesis
1 publication, 3.03%
Annual Reports in Medicinal Chemistry
Annual Reports in Medicinal Chemistry, 1, 3.03%
Annual Reports in Medicinal Chemistry
1 publication, 3.03%
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 1, 3.03%
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 3.03%
Russian Journal of Infection and Immunity, 1, 3.03%
Russian Journal of Infection and Immunity
1 publication, 3.03%
Reviews in Medical Virology
Reviews in Medical Virology, 1, 3.03%
Reviews in Medical Virology
1 publication, 3.03%
Biophysical Chemistry
Biophysical Chemistry, 1, 3.03%
Biophysical Chemistry
1 publication, 3.03%
Antiviral Research
Antiviral Research, 1, 3.03%
Antiviral Research
1 publication, 3.03%
1
2
3
4

Citations by publishers

1
2
3
4
5
6
7
8
9
Elsevier
Elsevier, 9, 27.27%
Elsevier
9 publications, 27.27%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 4, 12.12%
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 12.12%
Wiley
Wiley, 3, 9.09%
Wiley
3 publications, 9.09%
Thieme
Thieme, 3, 9.09%
Thieme
3 publications, 9.09%
Frontiers Media S.A.
Frontiers Media S.A., 2, 6.06%
Frontiers Media S.A.
2 publications, 6.06%
Springer Nature
Springer Nature, 2, 6.06%
Springer Nature
2 publications, 6.06%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 3.03%
American Chemical Society (ACS)
1 publication, 3.03%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 3.03%
Royal Society of Chemistry (RSC)
1 publication, 3.03%
Pleiades Publishing
Pleiades Publishing, 1, 3.03%
Pleiades Publishing
1 publication, 3.03%
Taylor & Francis
Taylor & Francis, 1, 3.03%
Taylor & Francis
1 publication, 3.03%
Dove Medical Press
Dove Medical Press, 1, 3.03%
Dove Medical Press
1 publication, 3.03%
Oxford University Press
Oxford University Press, 1, 3.03%
Oxford University Press
1 publication, 3.03%
Walter de Gruyter
Walter de Gruyter, 1, 3.03%
Walter de Gruyter
1 publication, 3.03%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 1, 3.03%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 3.03%
Saint Petersburg Pasteur Institute, 1, 3.03%
Saint Petersburg Pasteur Institute
1 publication, 3.03%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Makarov V. A. et al. Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses // ChemMedChem. 2015. Vol. 10. No. 10. pp. 1629-1634.
GOST all authors (up to 50) Copy
Makarov V. A., Braun H., Richter M., Riabova O. B., Kirchmair J., Kazakova E. S., Seidel N., Wutzler P., Schmidtke M. Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses // ChemMedChem. 2015. Vol. 10. No. 10. pp. 1629-1634.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/cmdc.201500304
UR - https://doi.org/10.1002%2Fcmdc.201500304
TI - Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
T2 - ChemMedChem
AU - Braun, Heike
AU - Richter, Martina
AU - Riabova, Olga B
AU - Kazakova, Elena S
AU - Seidel, Nora
AU - Makarov, Vadim A.
AU - Kirchmair, Johannes
AU - Wutzler, P.
AU - Schmidtke, Michaela
PY - 2015
DA - 2015/08/10 00:00:00
PB - Wiley
SP - 1629-1634
IS - 10
VL - 10
SN - 1860-7179
SN - 1860-7187
ER -
BibTex |
Cite this
BibTex Copy
@article{2015_Makarov,
author = {Heike Braun and Martina Richter and Olga B Riabova and Elena S Kazakova and Nora Seidel and Vadim A. Makarov and Johannes Kirchmair and P. Wutzler and Michaela Schmidtke},
title = {Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses},
journal = {ChemMedChem},
year = {2015},
volume = {10},
publisher = {Wiley},
month = {aug},
url = {https://doi.org/10.1002%2Fcmdc.201500304},
number = {10},
pages = {1629--1634},
doi = {10.1002/cmdc.201500304}
}
MLA
Cite this
MLA Copy
Makarov, Vadim A., et al. “Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses.” ChemMedChem, vol. 10, no. 10, Aug. 2015, pp. 1629-1634. https://doi.org/10.1002%2Fcmdc.201500304.
Found error?